These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism. Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651 [TBL] [Abstract][Full Text] [Related]
17. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models. Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637 [TBL] [Abstract][Full Text] [Related]